Clinical Trial

Analysis of the Role of the Microbiota in Diverticular Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A single-center, prospective observational cohort study conducted at the University Hospital of Navarra. The primary objective is to expand knowledge of diverticular disease and its pathological variants, as well as the influence of the microbiota in our environment, both clinically and molecularly; to describe the clinical and pathological characteristics of patients with diverticulosis and acute diverticulitis; to analyze any differences in the microbiota; and to identify the risk factors and groups associated with diverticular disease in order to establish the best strategies for prevention and treatment.
Trial Details
NCT Number NCT07681505
Lead Sponsor Hospital of Navarra
Conditions Diverticular Disease of Colon, Acute Diverticulitis, Gut Microbiota
Enrollment 285 participants
Start Date 2027-06-01
Primary Completion 2031-01-01 (estimated)
Study Completion 2032-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-02